Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
- Resource Type
- Review Article
- Source
- In
Critical Reviews in Oncology / Hematology December 2020 156 - Subject
- Language
- ISSN
- 1040-8428